首页> 外文期刊>The Internet Journal of Pain, Symptom Control and Palliative Care >A Brief Information Sheet On Opioid Effects Improves Quality Of Life In Cancer Patients On Opioids
【24h】

A Brief Information Sheet On Opioid Effects Improves Quality Of Life In Cancer Patients On Opioids

机译:阿片类药物作用的简要信息表改善了使用阿片类药物的癌症患者的生活质量

获取原文
       

摘要

Opioids are commonly employed in the treatment of severe pain in cancer patients. In an attempt to augment the benefit of quality of life obtained from the opioids, we prospectively evaluated the efficacy of a brief information sheet on opioid effects in 13 consecutive hospitalized cancer patients. They were randomized to receive (n=7) or not to recieve (n=6) this information sheet which shortly explained the likely side effects of and the indications for the opioids. EORTC QLQ-C30 was completed by each subject both at admission and discharge. Patients that received the information sheet had more improvement in fatigue, dyspnea, physical functioning and emotional functioning subscales (P=0.000, 0.043, 0.025 and 0.006, respectively). Our results suggest that increased awareness about the opioids, perhaps obtained from a written source, can better certain aspects of quality of life in cancer patients treated with these agents. This work was conducted by the departments of Medical Oncology and Internal Medicine at Akdeniz University Medical Faculty, in Antalya, Turkey. No support was recieved for this work. Introduction Pain is a common symptom for patients with advanced cancer[1, 2]. Control of pain in this group has been shown to improve quality of life[3]. One of the ways of quantifying various dimensions of quality of life in cancer patients is EORTC's quality of life questionnaire (EORTC QLQ-C30) that has previously been suggested[4]. However, it is not clear if awareness of various issues contributes to various aspects of quality of life, as determined by EORTC QLQ-C30 or other questionnaires or scales, in patients with advanced cancer in general and those on opioids in particular. Awareness of diagnosis in patients with advanced disease, for example, has been shown not to worsen quality of life[5], but to the best of our knowledge, no studies in the literature have addresses so far how, if any, awareness of other factors would influence quality of life in cancer patients using opioids. Thus, in this study, we aimed to investigate whether awareness of opioid effects (therapeutic or toxic) presented to cancer patients in written format would contribute to quality of life as assessed by EORTC QLQ-C30 in those treated with opioids. Patients And Methods PatientsThirteen consecutive cancer patients with either Eastern Cooperative Oncology Group (ECOG) performance status of 3 or 4, and with moderate or severe pain were recruited in the study. Prior to the study, these patients had had standard analgesics, non-opioids and opioids, on an outpatient basis, in compliance with the World Health Organisation's (WHO) analgesic ladder[6], but with no apparent treatment effect and were hospitalized mainly with the aim of better pain relief. Some of these patients had themselves requested hospitalization for faster pain control. MethodsAll patients at the time of admission were verbally and shortly informed about the opioid side effects and why an opioid at that stage was indicated. Patients were then randomized to receive or not to receive an information sheet that included the same details with oral explanation that was previously made. Additionally, it mentioned about the aim of opioid medication. This information sheet was half a page long and, in short, stated that the aim of the opioid treatment was the total disappearance of pain, and to reach this goal, frequent dose titrations, each at every few days, might be needed. Also, the common side effects were summarized. Patients had either oral morphine sulphate or transdermal fentanyl patch. In order to standardize the opioid dose, fentanyl doses were converted into corresponding equivalent morphine doses along with the previous suggestions of Payne et al[7 ]. Dose modifications were made at every 3 days, if needed. Patients were discharged when the degree of pain relief enabled outpatient follow-up and less intensive monitoring of the analgesic therapy. In order to assess quality of li
机译:阿片类药物通常用于治疗癌症患者的严重疼痛。为了增加从阿片类药物获得的生活质量的益处,我们前瞻性地评估了一份简短的关于阿片类药物作用的信息表在13位连续住院的癌症患者中的疗效。他们被随机分配接受(n = 7)或不接受(n = 6)此信息表,该信息表简要解释了阿片类药物的可能副作用和适应症。 EORTC QLQ-C30在入学和出院时均由每个受试者完成。收到该信息表的患者在疲劳,呼吸困难,身体功能和情绪功能子量表方面有更多的改善(分别为P = 0.000、0.043、0.025和0.006)。我们的结果表明,对阿片类药物的了解可能从书面资料中获得,可以改善接受这些药物治疗的癌症患者生活质量的某些方面。这项工作是由位于土耳其安塔利亚的阿克德尼兹大学医学院的肿瘤内科部门进行的。这项工作没有得到支持。简介疼痛是晚期癌症患者的常见症状[1、2]。控制该组疼痛可改善生活质量[3]。量化癌症患者生活质量各个维度的方法之一是先前提出的EORTC生活质量调查表(EORTC QLQ-C30)[4]。然而,目前尚不清楚由EORTC QLQ-C30或其他问卷或量表确定的各种问题的认识是否有助于一般癌症患者,尤其是阿片类药物患者的生活质量的各个方面。例如,已证明对晚期疾病患者的诊断意识不会使生活质量恶化[5],但据我们所知,迄今为止,没有文献研究涉及对其他疾病的认识(如果有的话)因素会影响使用阿片类药物的癌症患者的生活质量。因此,在这项研究中,我们旨在调查以EORTC QLQ-C30评估的阿片类药物治疗患者对书面形式的阿片类药物作用(治疗或毒性)的认识是否会有助于改善患者的生活质量。患者和方法患者本研究共招募了13名连续的癌症患者,这些患者的东部合作肿瘤小组(ECOG)的表现状态为3或4,并伴有中度或重度疼痛。在研究之前,这些患者在门诊就诊时均使用了标准镇痛药,非阿片类药物和阿片类药物,符合世界卫生组织(WHO)的镇痛阶梯法[6],但没有明显的治疗效果,并且主要接受了住院治疗。更好地缓解疼痛的目的。这些患者中有一些自己要求住院以更快地控制疼痛。方法入院时所有患者均通过口头和简短方式了解阿片类药物的副作用以及为何要在该阶段使用阿片类药物。然后将患者随机分为接受或不接受信息表,该信息表包括与先前做出的口头解释相同的细节。此外,它还提到了阿片类药物的目的。该信息页长达半页,简而言之,阿片类药物治疗的目的是使疼痛完全消失,为达到这一目标,可能需要每隔几天频繁滴定剂量。此外,总结了常见的副作用。患者口服硫酸吗啡或经皮芬太尼贴剂。为了使阿片类药物剂量标准化,将芬太尼剂量与Payne等人先前的建议[7]转换为相应的等效吗啡剂量。如果需要,每3天进行一次剂量调整。当缓解疼痛的程度能够对患者进行门诊随访并减少对止痛药的密集监测时,患者便可以出院。为了评估锂的质量

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号